Abstract
Driven by a steady improvement of computational hardware and significant progress in ab initio method development, quantum-mechanical approaches can now be applied to large biochemical systems and drug design. We review the methods implemented in GAMESS, which are suitable to calculate large biochemical systems. An emphasis is put on the fragment molecular orbital method (FMO) and quantum mechanics interfaced with molecular mechanics (QM/MM). The use of FMO in the protein-ligand binding, structure-activity relationship (SAR) studies, fragment- and structure-based drug design (FBDD/SBDD) is discussed in detail.
Keywords: Quantum chemistry, fragment molecular orbital, drug design, ab initio, GAMESS, FMO, QM/MM, FBDD, SBDD.
Current Topics in Medicinal Chemistry
Title:GAMESS As a Free Quantum-Mechanical Platform for Drug Research
Volume: 12 Issue: 18
Author(s): Yuri Alexeev, Michael P. Mazanetz, Osamu Ichihara and Dmitri G. Fedorov
Affiliation:
Keywords: Quantum chemistry, fragment molecular orbital, drug design, ab initio, GAMESS, FMO, QM/MM, FBDD, SBDD.
Abstract: Driven by a steady improvement of computational hardware and significant progress in ab initio method development, quantum-mechanical approaches can now be applied to large biochemical systems and drug design. We review the methods implemented in GAMESS, which are suitable to calculate large biochemical systems. An emphasis is put on the fragment molecular orbital method (FMO) and quantum mechanics interfaced with molecular mechanics (QM/MM). The use of FMO in the protein-ligand binding, structure-activity relationship (SAR) studies, fragment- and structure-based drug design (FBDD/SBDD) is discussed in detail.
Export Options
About this article
Cite this article as:
Alexeev Yuri, P. Mazanetz Michael, Ichihara Osamu and G. Fedorov Dmitri, GAMESS As a Free Quantum-Mechanical Platform for Drug Research, Current Topics in Medicinal Chemistry 2012; 12 (18) . https://dx.doi.org/10.2174/1568026611212180008
DOI https://dx.doi.org/10.2174/1568026611212180008 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clopidogrel Resistance: Implications for Coronary Stenting
Current Pharmaceutical Design Emerging Role of Angiotensin AT2 Receptor in Anti-Inflammation: An Update
Current Pharmaceutical Design Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense Strategy
Current Medicinal Chemistry Cystatin F Regulates Proteinase Activity in IL-2-activated Natural Killer Cells
Protein & Peptide Letters Evolving Strategies in Manipulating VEGF/VEGFR Signaling for the Promotion of Angiogenesis in Ischemic Muscle
Current Pharmaceutical Design Adalimumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Topics in Medicinal Chemistry Hemolysis, Platelet Aggregation and Antibacterial Activities of Human Antiphospholipid Antibody
Anti-Infective Agents Application of Mesenchymal Stem Cells to Age-related Neuronal Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Systemic Inflammation, Infection, ApoE Alleles, and Alzheimer Disease: A Position Paper
Current Alzheimer Research Human Mesenchymal Stem Cells (hMSCs) as Targets of DNA Damaging Agents in Cancer Therapy
Current Cancer Drug Targets Profiling of Proteins and Post Translational Modifications of Channa striatus Dried Meat
Current Proteomics Involvement of Adipogenic Potential of Human Bone Marrow Mesenchymal Stem Cells (MSCs) in Osteoporosis
Current Stem Cell Research & Therapy Role of Rifaximin in Inflammatory Bowel Disease Treatment
Mini-Reviews in Medicinal Chemistry Non-cirrhotic Portal Hypertension Associated with Didanosine and Streptococcus agalactiae Infection: A Case Report
Reviews on Recent Clinical Trials Antiviral Therapy for Chronic Hepatitis B: A Review
Current Drug Targets - Inflammation & Allergy Peptide Therapeutics in Neurodegenerative Disorders
Current Medicinal Chemistry Current Advances in Gene Therapy for the Treatment of Genodermatoses
Current Gene Therapy Epigenetic Aberrations and Targeted Epigenetic Therapy of Esophageal Cancer
Current Cancer Drug Targets Viral Anti-Inflammatory Proteins: The Potential for Immunotherapeutic Applications in Cancer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry